Jessica Krack

Jessica Krack's Title

Jessica Krack holds the prominent position of Head of HR. In this role, she oversees the human resources department, ensuring that the organization attracts, retains, and develops top talent. Her leadership in HR is crucial for fostering a positive work environment and aligning HR strategies with the company's goals.

Jessica Krack's Expertise

Jessica Krack is renowned for her specialization in synthesizing complex DNA sequences, which are often deemed challenging or impossible by traditional methods. Her expertise includes handling sequences with unique features such as high or low GC content, multiple repeats, and intricate secondary structures. This specialization positions her as a key figure in advancing genetic research and biotechnological applications.

Jessica Krack's Contributions to DNA Synthesis Technology

Jessica Krack is at the forefront of enzymatic DNA synthesis, providing sequences up to 600 base pairs as clonal genes or gene fragments. Her work ensures that these sequences are delivered with precision and accuracy, utilizing the pANSA_v1_ vector, which includes an ampicillin resistance marker and is compatible with Golden Gate Cloning. This innovation is pivotal for researchers who require reliable and high-quality genetic materials.

Jessica Krack's Turnaround Time for DNA Synthesis

Efficiency and prompt delivery are hallmarks of Jessica Krack's services. She aims for a turnaround time of 18-22 business days for clonal genes and an impressive 7-10 business days for gene fragments under the Early Access Program. This quick turnaround is critical for researchers who need timely access to synthesized DNA for their experiments and projects.

Jessica Krack's Industry Engagement

Jessica Krack actively contributes to the scientific community, as evidenced by her participation in the Global Synthetic Biology Conference. At this prestigious event, she presented on the advancements in enzymatic DNA synthesis technology, showcasing her deep knowledge and the impactful work she spearheads. Her engagement with the industry highlights her commitment to driving forward the field of synthetic biology.